Related Experiment Video
Updated: Jun 10, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation
Y H Tsang1, A Lamb, J Romero-Gallo
1Department of Biochemistry, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Abstract:
Chronic infection with cagA-positive Helicobacter pylori is the strongest risk factor for the development of gastric adenocarcinoma. The cagA gene product CagA is injected into gastric epithelial cells and disturbs cellular functions by physically interacting with and deregulating a variety of cellular signaling molecules. RUNX3 is a tumor suppressor in many tissues, and it is frequently inactivated in gastric cancer. In this study, we show that H. pylori infection inactivates the gastric tumor suppressor RUNX3 in a CagA-dependent manner. CagA directly associates with RUNX3 through a specific recognition of the PY motif of RUNX3 by a WW domain of CagA. Deletion of the WW domains of CagA or mutation of the PY motif in RUNX3 abolishes the ability of CagA to induce the ubiquitination and degradation of RUNX3, thereby extinguishing its ability to inhibit the transcriptional activation of RUNX3. Our studies identify RUNX3 as a novel cellular target of H. pylori CagA and also reveal a mechanism by which CagA functions as an oncoprotein by blocking the activity of gastric tumor suppressor RUNX3.
Insights
Helicobacter pylori infection inactivates the gastric tumor suppressor RUNX3 via its CagA protein. This interaction blocks RUNX3
Area of Science:
- Oncology
- Microbiology
- Molecular Biology
Background:
- Chronic Helicobacter pylori infection is a major risk factor for gastric cancer.
- The cagA-positive strain of H. pylori injects the CagA protein into gastric cells, disrupting cellular functions.
- RUNX3 is a known tumor suppressor frequently inactivated in gastric cancer.
Purpose of the Study:
- To investigate the mechanism by which H. pylori infection inactivates the gastric tumor suppressor RUNX3.
- To identify RUNX3 as a novel cellular target of H. pylori CagA.
- To elucidate how CagA functions as an oncoprotein by targeting RUNX3.
Main Methods:
- Investigated the interaction between H. pylori CagA and RUNX3 in gastric epithelial cells.
- Utilized deletion mutants of CagA and mutated RUNX3 to study the CagA-RUNX3 interaction.
- Assessed the effects of CagA on RUNX3 ubiquitination, degradation, and transcriptional activity.
Main Results:
- H. pylori infection inactivates RUNX3 in a CagA-dependent manner.
- CagA directly binds to RUNX3 via its WW domain recognizing RUNX3's PY motif.
- CagA promotes RUNX3 ubiquitination and degradation, inhibiting its transcriptional activity.
Conclusions:
- RUNX3 is a novel cellular target of H. pylori CagA.
- CagA acts as an oncoprotein by blocking the activity of the gastric tumor suppressor RUNX3.
- This mechanism contributes to the development of gastric adenocarcinoma.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Abnormal Proliferation
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
